Kyntra Bio, Inc. (KYNB) stock
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−1.16 (-36.25%)
Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –
Kyntra Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kyntra Bio's price to book ratio was 84.3× on Jan 31, 2023, against 4.3× a year earlier. Over the last 5 years it ranged from 3.2× to 84.3×, with a median of 7.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 84.3× | +27.1 |
| 2022 | Dec 30, 2022 | 57.2× | +53.2 |
| 2021 | Dec 31, 2021 | 4.0× | −3.5 |
| 2020 | Dec 31, 2020 | 7.5× | +1.2 |
| 2019 | Dec 31, 2019 | 6.3× | −2.0 |
| 2018 | Dec 31, 2018 | 8.3× | +1.5 |
| 2017 | Dec 29, 2017 | 6.8× | −0.8 |
| 2016 | Dec 30, 2016 | 7.6× | −1.0 |
| 2015 | Dec 31, 2015 | 8.6× | – |
See a number that looks wrong?